Skip to main navigation
Skip to search
Skip to main content
University Medical Center Utrecht Home
Help & FAQ
Home
Profiles
Research units
Research output
Activities
Prizes
Press/Media
Search by expertise, name or affiliation
Data Safety Monitoring Board of OPT-JIA
Wulffraat, N. M.
(Consultant)
Cluster B
Rheumatology Research 1
Child Health
Infection & Immunity
Regenerative Medicine and Stem Cells
Activity
:
Consultancy
›
Academic
Description
member of the DSMB Committee for a pragmatic trial assessing the effectiveness of ondansetron in preventing MTX intolerance in JIA patients. The PI of the study is Jamie Guzman.
Period
20 Jan 2019
→ …
Degree of Recognition
International
Keywords
MTX
Intolerance
JIA
X